Skip to main content
SpringerLink
Log in

Clinical Trials on Management of Pain in Parkinson’s Disease

  • Protocol
  • First Online:
Clinical Trials In Parkinson's Disease

Part of the book series: Neuromethods ((NM,volume 160))

  • 577 Accesses

Abstract

Pain is highly prevalent in Parkinson’s disease (PD). It is one of the most common nonmotor symptoms of PD, and it may precede motor symptoms by several years. There are various types of pain described in PD, reflecting its heterogeneity and multifactorial origin. Pain in PD has been reported to differ between gender, early and advanced stages of PD, motor and nonmotor subtypes, and to fluctuate during on and off states. For the management of pain, it is crucial to separate PD-related pain from pain of other origins. Pain has a negative impact on the overall quality of life in PD patients. Early recognition and holistic assessment of pain are therefore important for personalized medicine delivery.

When conducting a clinical trial in pain, study methodology and design need to be tailored to the multifaceted features of PD pain. The used assessment tools ideally have to be specific and sensitive to these features.

In this book chapter, we discuss and outline the evaluation of PD-related pain, review PD general and specific pain assessment tools, and discuss relevant clinical trials addressing treatment of pain in PD.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Garcia-Ruiz PJ, Chaudhuri KR, Martinez-Martin P (2014) Non-motor symptoms of Parkinson’s disease. A review...from the past. J Neurol Sci 338:30–33

    Article  PubMed  Google Scholar 

  2. Baig F, Lawton M, Rolinski M et al (2015) Delineating nonmotor symptoms in early Parkinson’s disease and first-degree relatives. Mov Disord 30:1759–1766

    Article  PubMed  PubMed Central  Google Scholar 

  3. Classen J, Koschel J, Oehlwein C et al (2017) Nonmotor fluctuations: phenotypes, pathophysiology, management, and open issues. J Neural Transm (Vienna) 124:1029–1036

    Article  Google Scholar 

  4. Schrag A (2006) Quality of life and depression in Parkinson’s disease. J Neurol Sci 248:151–157

    Article  PubMed  Google Scholar 

  5. Valkovic P, Minar M, Singliarova H et al (2015) Pain in Parkinson’s disease: a cross-sectional study of its prevalence, types, and relationship to depression and quality of life. PLoS One 10:e0136541

    Article  PubMed  PubMed Central  Google Scholar 

  6. Skogar O, Lokk J (2016) Pain management in patients with Parkinson’s disease: challenges and solutions. J Multidiscip Healthc 9:469–479

    Article  PubMed  PubMed Central  Google Scholar 

  7. Chaudhuri KR, Schapira AH (2009) Non-motor symptoms of Parkinson’s disease: dopaminergic pathophysiology and treatment. Lancet Neurol 8:464–474

    Article  CAS  PubMed  Google Scholar 

  8. Chaudhuri KR, Prieto-Jurcynska C, Naidu Y et al (2010) The nondeclaration of nonmotor symptoms of Parkinson’s disease to health care professionals: an international study using the nonmotor symptoms questionnaire. Mov Disord 25:704–709

    Article  PubMed  Google Scholar 

  9. Mitra T, Naidu Y, Martinez-Martin P (2008) The non declaration of non motor symptoms of Parkinson’s disease to healthcare professionals. An international survey using the NMSQuest. In: 6th international congress on mental dysfunctions and other non-motor features in Parkinson’s disease and related disorders. Dresden, October

    Google Scholar 

  10. Beiske AG, Loge JH, Ronningen A et al (2009) Pain in Parkinson’s disease: prevalence and characteristics. Pain 141:173–177

    Article  CAS  PubMed  Google Scholar 

  11. Broen MP, Braaksma MM, Patijn J et al (2012) Prevalence of pain in Parkinson’s disease: a systematic review using the modified QUADAS tool. Mov Disord 27:480–484

    Article  PubMed  Google Scholar 

  12. Ha AD, Jankovic J (2012) Pain in Parkinson’s disease. Mov Disord 27:485–491

    Article  PubMed  Google Scholar 

  13. Negre-Pages L, Regragui W, Bouhassira D et al (2008) Chronic pain in Parkinson’s disease: the cross-sectional French DoPaMiP survey. Mov Disord 23:1361–1369

    Article  PubMed  Google Scholar 

  14. Cury RG, Galhardoni R, Fonoff ET et al (2016) Sensory abnormalities and pain in Parkinson disease and its modulation by treatment of motor symptoms. Eur J Pain 20:151–165

    Article  CAS  PubMed  Google Scholar 

  15. Madden MB, Hall DA (2010) Shoulder pain in Parkinson’s disease: a case-control study. Mov Disord 25:1105–1106

    Article  PubMed  Google Scholar 

  16. Ehrt U, Larsen JP, Aarsland D (2009) Pain and its relationship to depression in Parkinson disease. Am J Geriatr Psychiatry 17:269–275

    Article  PubMed  Google Scholar 

  17. Defazio G, Berardelli A, Fabbrini G et al (2008) Pain as a nonmotor symptom of Parkinson disease: evidence from a case-control study. Arch Neurol 65:1191–1194

    Article  PubMed  Google Scholar 

  18. Broetz D, Eichner M, Gasser T et al (2007) Radicular and nonradicular back pain in Parkinson’s disease: a controlled study. Mov Disord 22:853–856

    Article  PubMed  Google Scholar 

  19. Chaudhuri KR, Martinez-Martin P, Schapira AH et al (2006) International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson’s disease: the NMSQuest study. Mov Disord 21:916–923

    Article  PubMed  Google Scholar 

  20. Etchepare F, Rozenberg S, Mirault T et al (2006) Back problems in Parkinson’s disease: an underestimated problem. Joint Bone Spine 73:298–302

    Article  PubMed  Google Scholar 

  21. Quittenbaum BH, Grahn B (2004) Quality of life and pain in Parkinson’s disease: a controlled cross-sectional study. Parkinsonism Relat Disord 10:129–136

    Article  PubMed  Google Scholar 

  22. Snider SR, Fahn S, Isgreen WP et al (1976) Primary sensory symptoms in parkinsonism. Neurology 26:423–429

    Article  CAS  PubMed  Google Scholar 

  23. Ozturk EA, Gundogdu I, Kocer B et al (2016) Chronic pain in Parkinson’s disease: frequency, characteristics, independent factors, and relationship with health-related quality of life. J Back Musculoskelet Rehabil. https://doi.org/10.3233/BMR-160720

  24. Rana A, Saeed U, Masroor MS et al (2013) A cross-sectional study investigating clinical predictors and physical experiences of pain in Parkinson’s disease. Funct Neurol 28:297–304

    PubMed  Google Scholar 

  25. Wen HB, Zhang ZX, Wang H et al (2012) Epidemiology and clinical phenomenology for Parkinson’s disease with pain and fatigue. Parkinsonism Relat Disord 18(Suppl 1):S222–S225

    Article  PubMed  PubMed Central  Google Scholar 

  26. Hanagasi HA, Akat S, Gurvit H et al (2011) Pain is common in Parkinson’s disease. Clin Neurol Neurosurg 113:11–13

    Article  PubMed  Google Scholar 

  27. Santos-Garcia D, Abella-Corral J, Aneiros-Diaz A et al (2011) Pain in Parkinson’s disease: prevalence, characteristics, associated factors, and relation with other non motor symptoms, quality of life, autonomy, and caregiver burden. Rev Neurol 52:385–393

    PubMed  Google Scholar 

  28. Silva EG, Viana MA, Quagliato EM (2008) Pain in Parkinson’s disease: analysis of 50 cases in a clinic of movement disorders. Arq Neuropsiquiatr 66:26–29

    Article  PubMed  Google Scholar 

  29. Stamey W, Davidson A, Jankovic J (2008) Shoulder pain: a presenting symptom of Parkinson disease. J Clin Rheumatol 14:253–254

    Article  PubMed  Google Scholar 

  30. Martinez-Martin P, Schapira AH, Stocchi F et al (2007) Prevalence of nonmotor symptoms in Parkinson’s disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. Mov Disord 22:1623–1629

    Article  PubMed  Google Scholar 

  31. Sullivan KL, Ward CL, Hauser RA et al (2007) Prevalence and treatment of non-motor symptoms in Parkinson’s disease. Parkinsonism Relat Disord 13:545

    Article  PubMed  Google Scholar 

  32. Lee MA, Walker RW, Hildreth TJ et al (2006) A survey of pain in idiopathic Parkinson’s disease. J Pain Symptom Manag 32:462–469

    Article  Google Scholar 

  33. Tinazzi M, Del Vesco C, Fincati E et al (2006) Pain and motor complications in Parkinson’s disease. J Neurol Neurosurg Psychiatry 77:822–825

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Clifford TJ, Warsi MJ, Burnett CA et al (1998) Burning mouth in Parkinson’s disease sufferers. Gerodontology 15:73–78

    Article  CAS  PubMed  Google Scholar 

  35. Goetz CG, Tanner CM, Levy M et al (1986) Pain in Parkinson’s disease. Mov Disord 1:45–49

    Article  CAS  PubMed  Google Scholar 

  36. Rana AQ, Kabir A, Jesudasan M et al (2013) Pain in Parkinson’s disease: analysis and literature review. Clin Neurol Neurosurg 115:2313–2317

    Article  PubMed  Google Scholar 

  37. Thompson T, Gallop K, Correll CU et al (2017) Pain perception in Parkinson’s disease: a systematic review and meta-analysis of experimental studies. Ageing Res Rev 35:74–86

    Article  PubMed  Google Scholar 

  38. Jarcho JM, Mayer EA, Jiang ZK et al (2012) Pain, affective symptoms, and cognitive deficits in patients with cerebral dopamine dysfunction. Pain 153:744–754

    Article  CAS  PubMed  Google Scholar 

  39. Wood PB (2008) Role of central dopamine in pain and analgesia. Expert Rev Neurother 8:781–797

    Article  CAS  PubMed  Google Scholar 

  40. Avenali M, Tassorelli C, De Icco R et al (2017) Pain processing in atypical Parkinsonisms and Parkinson disease: a comparative neurophysiological study. Clin Neurophysiol 128:1978–1984

    Article  PubMed  Google Scholar 

  41. Djaldetti R, Shifrin A, Rogowski Z et al (2004) Quantitative measurement of pain sensation in patients with Parkinson disease. Neurology 62:2171–2175

    Article  CAS  PubMed  Google Scholar 

  42. Zambito Marsala S, Tinazzi M, Vitaliani R et al (2011) Spontaneous pain, pain threshold, and pain tolerance in Parkinson’s disease. J Neurol 258:627–633

    Article  PubMed  Google Scholar 

  43. Gierthmuhlen J, Schumacher S, Deuschl G et al (2010) Somatosensory function in asymptomatic Parkin-mutation carriers. Eur J Neurol 17:513–517

    Article  CAS  PubMed  Google Scholar 

  44. Nolano M, Provitera V, Estraneo A et al (2008) Sensory deficit in Parkinson’s disease: evidence of a cutaneous denervation. Brain 131:1903–1911

    Article  PubMed  Google Scholar 

  45. Mylius V, Engau I, Teepker M et al (2009) Pain sensitivity and descending inhibition of pain in Parkinson’s disease. J Neurol Neurosurg Psychiatry 80:24–28

    Article  CAS  PubMed  Google Scholar 

  46. Perrotta A, Sandrini G, Serrao M et al (2011) Facilitated temporal summation of pain at spinal level in Parkinson’s disease. Mov Disord 26:442–448

    Article  PubMed  Google Scholar 

  47. Schestatsky P, Kumru H, Valls-Sole J et al (2007) Neurophysiologic study of central pain in patients with Parkinson disease. Neurology 69:2162–2169

    Article  CAS  PubMed  Google Scholar 

  48. Tinazzi M, Del Vesco C, Defazio G et al (2008) Abnormal processing of the nociceptive input in Parkinson’s disease: a study with CO2 laser evoked potentials. Pain 136:117–124

    Article  PubMed  Google Scholar 

  49. Braak H, Sastre M, Bohl JR et al (2007) Parkinson’s disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons. Acta Neuropathol 113:421–429

    Article  PubMed  Google Scholar 

  50. Defazio G, Antonini A, Tinazzi M et al (2017) Relationship between pain and motor and non-motor symptoms in Parkinson’s disease. Eur J Neurol 24:974–980

    Article  CAS  PubMed  Google Scholar 

  51. Allen NE, Wong CM, Canning CG et al (2016) The association between Parkinson’s disease motor impairments and pain. Pain Med 17:456–462

    PubMed  Google Scholar 

  52. Franke C, Storch A (2017) Nonmotor fluctuations in Parkinson’s disease. Int Rev Neurobiol 134:947–971

    Article  PubMed  Google Scholar 

  53. Storch A, Schneider CB, Wolz M et al (2013) Nonmotor fluctuations in Parkinson disease: severity and correlation with motor complications. Neurology 80:800–809

    Article  PubMed  Google Scholar 

  54. Yakovleva LA, Zalyalova ZA, Altunbaev RA (2015) Pain fluctuations in Parkinson’s disease. Zh Nevrol Psikhiatr Im S S Korsakova 115:41–44

    Article  CAS  PubMed  Google Scholar 

  55. Lin CH, Wu RM, Chang HY et al (2013) Preceding pain symptoms and Parkinson’s disease: a nationwide population-based cohort study. Eur J Neurol 20:1398–1404

    Article  PubMed  Google Scholar 

  56. Schrag A, Horsfall L, Walters K et al (2015) Prediagnostic presentations of Parkinson’s disease in primary care: a case-control study. Lancet Neurol 14:57–64

    Article  PubMed  Google Scholar 

  57. Tolosa E, Compta Y, Gaig C (2007) The premotor phase of Parkinson’s disease. Parkinsonism Relat Disord 13(Suppl):S2–S7

    Article  PubMed  Google Scholar 

  58. O’sullivan SS, Williams DR, Gallagher DA et al (2008) Nonmotor symptoms as presenting complaints in Parkinson’s disease: a clinicopathological study. Mov Disord 23:101–106

    Article  PubMed  Google Scholar 

  59. Georgiev D, Hamberg K, Hariz M et al (2017) Gender differences in Parkinson’s disease: a clinical perspective. Acta Neurol Scand 136:570–584

    Article  CAS  PubMed  Google Scholar 

  60. Greenspan JD, Craft RM, Leresche L et al (2007) Studying sex and gender differences in pain and analgesia: a consensus report. Pain 132(Suppl 1):S26–S45

    Article  PubMed  PubMed Central  Google Scholar 

  61. Keogh E, Denford S (2009) Sex differences in perceptions of pain coping strategy usage. Eur J Pain 13:629–634

    Article  PubMed  Google Scholar 

  62. Bruno VA, Fox SH, Mancini D et al (2016) Botulinum toxin use in refractory pain and other symptoms in Parkinsonism. Can J Neurol Sci 43:697–702

    Article  PubMed  Google Scholar 

  63. Rana AQ, Qureshi ARM, Kachhvi HB et al (2016) Increased likelihood of anxiety and poor sleep quality in Parkinson’s disease patients with pain. J Neurol Sci 369:212–215

    Article  PubMed  Google Scholar 

  64. Ford B (1998) Pain in Parkinson’s disease. Clin Neurosci 5:63–72

    CAS  PubMed  Google Scholar 

  65. Wasner G, Deuschl G (2012) Pains in Parkinson disease—many syndromes under one umbrella. Nat Rev Neurol 8:284–294

    Article  CAS  PubMed  Google Scholar 

  66. Sauerbier A, Rosa-Grilo M, Qamar MA et al (2017) Nonmotor subtyping in Parkinson’s disease. Int Rev Neurobiol 133:447–478

    Article  PubMed  Google Scholar 

  67. Quinn NP, Koller WC, Lang AE et al (1986) Painful Parkinson’s disease. Lancet 1:1366–1369

    Article  CAS  PubMed  Google Scholar 

  68. Wallace VC, Chaudhuri KR (2014) Unexplained lower limb pain in Parkinson’s disease: a phenotypic variant of “painful Parkinson’s disease”. Parkinsonism Relat Disord 20:122–124

    Article  PubMed  Google Scholar 

  69. Bonuccelli U (2015) Effects of safinamide on motor complications and pain in advancing Parkinson’s disease – post hoc analyses of pivotal trials. Eur Neurol Rev 10(2):176–181

    Article  Google Scholar 

  70. Perez-Lloret S, Ciampi De Andrade D, Lyons KE et al (2016) Rating scales for pain in Parkinson’s disease: critique and recommendations. Mov Disord Clin Pract 3:527–537

    Article  PubMed  PubMed Central  Google Scholar 

  71. Chaudhuri KR, Rizos A, Trenkwalder C et al (2015) King’s Parkinson’s disease pain scale, the first scale for pain in PD: an international validation. Mov Disord 30:1623–1631

    Article  PubMed  Google Scholar 

  72. Cleeland CS, Ryan KM (1994) Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singap 23:129–138

    CAS  PubMed  Google Scholar 

  73. Melzack R (1975) The McGill Pain Questionnaire: major properties and scoring methods. Pain 1:277–299

    Article  CAS  PubMed  Google Scholar 

  74. Melzack R (1987) The short-form McGill Pain Questionnaire. Pain 30:191–197

    Article  CAS  PubMed  Google Scholar 

  75. Breivik H, Borchgrevink PC, Allen SM et al (2008) Assessment of pain. Br J Anaesth 101:17–24

    Article  CAS  PubMed  Google Scholar 

  76. Huskisson E (ed) (1983) Visual analogue scales, pain measurement and assessment. Raven Press, New York, NY

    Google Scholar 

  77. Bennett M (2001) The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs. Pain 92:147–157

    Article  CAS  PubMed  Google Scholar 

  78. Bouhassira D, Attal N, Fermanian J et al (2004) Development and validation of the Neuropathic Pain Symptom Inventory. Pain 108:248–257

    Article  PubMed  Google Scholar 

  79. Freynhagen R, Baron R, Gockel U et al (2006) painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin 22:1911–1920

    Article  PubMed  Google Scholar 

  80. Gaston-Johansson F (1996) Measurement of pain: the psychometric properties of the Pain-O-Meter, a simple, inexpensive pain assessment tool that could change health care practices. J Pain Symptom Manag 12:172–181

    Article  CAS  Google Scholar 

  81. Bouhassira D, Attal N, Alchaar H et al (2005) Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 114:29–36

    Article  PubMed  Google Scholar 

  82. Atkinson TM, Mendoza TR, Sit L et al (2010) The Brief Pain Inventory and its “pain at its worst in the last 24 hours” item: clinical trial endpoint considerations. Pain Med 11:337–346

    Article  PubMed  PubMed Central  Google Scholar 

  83. Mendoza T, Mayne T, Rublee D et al (2006) Reliability and validity of a modified Brief Pain Inventory short form in patients with osteoarthritis. Eur J Pain 10:353–361

    Article  PubMed  Google Scholar 

  84. Gjeilo KH, Stenseth R, Wahba A et al (2007) Validation of the brief pain inventory in patients six months after cardiac surgery. J Pain Symptom Manag 34:648–656

    Article  Google Scholar 

  85. Konno S, Oda N, Ochiai T et al (2016) Randomized, double-blind, placebo-controlled phase III trial of duloxetine monotherapy in japanese patients with chronic low back pain. Spine (Phila Pa 1976) 41:1709–1717

    Article  Google Scholar 

  86. Lin XJ, Yu N, Lin XG et al (2016) A clinical survey of pain in Parkinson’s disease in Eastern China. Int Psychogeriatr 28:283–289

    Article  PubMed  Google Scholar 

  87. Djaldetti R, Yust-Katz S, Kolianov V et al (2007) The effect of duloxetine on primary pain symptoms in Parkinson disease. Clin Neuropharmacol 30:201–205

    Article  CAS  PubMed  Google Scholar 

  88. Madeo G, Schirinzi T, Natoli S et al (2015) Efficacy and safety profile of prolonged release oxycodone in combination with naloxone (OXN PR) in Parkinson’s disease patients with chronic pain. J Neurol 262:2164–2170

    Article  CAS  PubMed  Google Scholar 

  89. Rana AQ, Siddiqui I, Mosabbir A et al (2013) Association of pain, Parkinson’s disease, and restless legs syndrome. J Neurol Sci 327:32–34

    Article  PubMed  Google Scholar 

  90. Burckhardt CS, Jones KD (2003) Adult measures of pain: the McGill Pain Questionnaire (MPQ), Rheumatoid Arthritis Pain Scale (RAPS), Short-Form McGill Pain Questionnaire (SF-MPQ), Verbal Descriptive Scale (VDS), Visual Analog Scale (VAS), and West Haven-Yale Multidisciplinary Pain Inventory (WHYMPI). Arthritis Care Res 49:S96–S104

    Article  Google Scholar 

  91. Rascol O, Zesiewicz T, Chaudhuri KR et al (2016) A randomized controlled exploratory pilot study to evaluate the effect of rotigotine transdermal patch on Parkinson’s disease-associated chronic pain. J Clin Pharmacol 56:852–861

    Article  CAS  PubMed  Google Scholar 

  92. Trenkwalder C, Chaudhuri KR, Martinez-Martin P et al (2015) Prolonged-release oxycodone-naloxone for treatment of severe pain in patients with Parkinson’s disease (PANDA): a double-blind, randomised, placebo-controlled trial. Lancet Neurol 14:1161–1170

    Article  CAS  PubMed  Google Scholar 

  93. Martinez-Martin P, Manuel Rojo-Abuin J, Rizos A et al (2017) Distribution and impact on quality of life of the pain modalities assessed by the King’s Parkinson’s disease pain scale. NPJ Parkinsons Dis 3:8

    Article  PubMed  PubMed Central  Google Scholar 

  94. Polli A, Weis L, Biundo R et al (2016) Anatomical and functional correlates of persistent pain in Parkinson’s disease. Mov Disord 31:1854–1864

    Article  PubMed  Google Scholar 

  95. Lin CH, Chaudhuri KR, Fan JY et al (2017) Depression and catechol-O-methyltransferase (COMT) genetic variants are associated with pain in Parkinson’s disease. Sci Rep 7:6306

    Article  PubMed  PubMed Central  Google Scholar 

  96. Chaudhuri KR, Martinez-Martin P, Brown RG et al (2007) The metric properties of a novel non-motor symptoms scale for Parkinson’s disease: results from an international pilot study. Mov Disord 22:1901–1911

    Article  PubMed  Google Scholar 

  97. Fabbri M, Coelho M, Guedes LC et al (2017) Response of non-motor symptoms to levodopa in late-stage Parkinson’s disease: results of a levodopa challenge test. Parkinsonism Relat Disord 39:37–43

    Article  PubMed  Google Scholar 

  98. Honig H, Antonini A, Martinez-Martin P et al (2009) Intrajejunal levodopa infusion in Parkinson’s disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life. Mov Disord 24:1468–1474

    Article  PubMed  Google Scholar 

  99. Wirdefeldt K, Odin P, Nyholm D (2016) Levodopa-carbidopa intestinal gel in patients with Parkinson’s disease: a systematic review. CNS Drugs 30:381–404

    Article  CAS  PubMed  Google Scholar 

  100. Fasano A, Ricciardi L, Lena F et al (2012) Intrajejunal levodopa infusion in advanced Parkinson’s disease: long-term effects on motor and non-motor symptoms and impact on patient’s and caregiver’s quality of life. Eur Rev Med Pharmacol Sci 16:79–89

    CAS  PubMed  Google Scholar 

  101. Reddy P, Martinez-Martin P, Brown RG et al (2014) Perceptions of symptoms and expectations of advanced therapy for Parkinson’s disease: preliminary report of a Patient-Reported Outcome tool for Advanced Parkinson’s disease (PRO-APD). Health Qual Life Outcomes 12:11

    Article  PubMed  PubMed Central  Google Scholar 

  102. Caceres-Redondo MT, Carrillo F, Lama MJ et al (2014) Long-term levodopa/carbidopa intestinal gel in advanced Parkinson’s disease. J Neurol 261:561–569

    Article  CAS  PubMed  Google Scholar 

  103. Martinez-Martin P, Reddy P, Katzenschlager R et al (2015) EuroInf: a multicenter comparative observational study of apomorphine and levodopa infusion in Parkinson’s disease. Mov Disord 30:510–516

    Article  CAS  PubMed  Google Scholar 

  104. Bohlega S, Abou Al-Shaar H, Alkhairallah T et al (2015) Levodopa-carbidopa intestinal gel infusion therapy in advanced Parkinson’s disease: single Middle Eastern Center experience. Eur Neurol 74:227–236

    Article  CAS  PubMed  Google Scholar 

  105. Antonini A, Odin P, Opiano L et al (2013) Effect and safety of duodenal levodopa infusion in advanced Parkinson’s disease: a retrospective multicenter outcome assessment in patient routine care. J Neural Transm 120:1553–1558

    Article  CAS  PubMed  Google Scholar 

  106. Sensi M, Preda F, Trevisani L et al (2014) Emerging issues on selection criteria of levodopa carbidopa infusion therapy: considerations on outcome of 28 consecutive patients. J Neural Transm (Vienna) 121:633–642

    Article  CAS  Google Scholar 

  107. Zibetti M, Merola A, Artusi CA et al (2014) Levodopa/carbidopa intestinal gel infusion in advanced Parkinson’s disease: a 7-year experience. Eur J Neurol 21:312–318

    Article  CAS  PubMed  Google Scholar 

  108. Trenkwalder C, Kies B, Rudzinska M et al (2011) Rotigotine effects on early morning motor function and sleep in Parkinson’s disease: a double-blind, randomized, placebo-controlled study (RECOVER). Mov Disord 26:90–99

    Article  PubMed  Google Scholar 

  109. Park D (2017) Pramipexole-induced limb dystonia and its associated complex regional pain syndrome in idiopathic Parkinson’s disease: a case report. Medicine 96:e7530

    Article  PubMed  PubMed Central  Google Scholar 

  110. Letvinenko IV, Odinak MM, Mogil'naia VI (2008) Pain and depression in Parkinson’s disease: new therapeutic possibilities of pramipexole. Zh Nevrol Psikhiatr Im S S Korsakova 108:36–38

    CAS  PubMed  Google Scholar 

  111. Stuginski-Barbosa J, Rodrigues GG, Bigal ME et al (2008) Burning mouth syndrome responsive to pramipexol. J Headache Pain 9:43–45

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  112. Makumi CW, Asgharian A, Ellis J et al (2016) Long-term, open-label, safety study of once-daily ropinirole extended/prolonged release in early and advanced Parkinson’s disease. Int J Neurosci 126:30–38

    Article  PubMed  Google Scholar 

  113. Nashatizadeh MM, Lyons KE, Pahwa R (2009) A review of ropinirole prolonged release in Parkinson’s disease. Clin Interv Aging 4:179–186

    CAS  PubMed  PubMed Central  Google Scholar 

  114. Pacchetti C, Albani G, Martignoni E et al (1995) “Off” painful dystonia in Parkinson’s disease treated with botulinum toxin. Mov Disord 10:333–336

    Article  CAS  PubMed  Google Scholar 

  115. Nishioka K, Nakajima M (2015) Beneficial therapeutic effects of spinal cord stimulation in advanced cases of Parkinson’s disease with intractable chronic pain: a case series. Neuromodulation 18:751–753

    Article  PubMed  Google Scholar 

  116. Fenelon G, Goujon C, Gurruchaga JM et al (2012) Spinal cord stimulation for chronic pain improved motor function in a patient with Parkinson’s disease. Parkinsonism Relat Disord 18:213–214

    Article  PubMed  Google Scholar 

  117. Geroin C, Gandolfi M, Bruno V et al (2016) Integrated approach for pain management in Parkinson disease. Curr Neurol Neurosci Rep 16:28

    Article  PubMed  Google Scholar 

  118. Oakley JC, Prager JP (2002) Spinal cord stimulation: mechanisms of action. Spine (Phila Pa 1976) 27:2574–2583

    Article  Google Scholar 

  119. Kim HJ, Paek SH, Kim JY et al (2008) Chronic subthalamic deep brain stimulation improves pain in Parkinson disease. J Neurol 255:1889–1894

    Article  PubMed  Google Scholar 

  120. Loher TJ, Burgunder JM, Weber S et al (2002) Effect of chronic pallidal deep brain stimulation on off period dystonia and sensory symptoms in advanced Parkinson’s disease. J Neurol Neurosurg Psychiatry 73:395–399

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  121. Witjas T, Kaphan E, Regis J et al (2007) Effects of chronic subthalamic stimulation on nonmotor fluctuations in Parkinson’s disease. Mov Disord 22:1729–1734

    Article  PubMed  Google Scholar 

  122. Gierthmuhlen J, Arning P, Binder A et al (2010) Influence of deep brain stimulation and levodopa on sensory signs in Parkinson’s disease. Mov Disord 25:1195–1202

    Article  PubMed  Google Scholar 

  123. Maruo T, Saitoh Y, Hosomi K et al (2011) Deep brain stimulation of the subthalamic nucleus improves temperature sensation in patients with Parkinson’s disease. Pain 152:860–865

    Article  PubMed  Google Scholar 

  124. Spielberger S, Wolf E, Kress M et al (2011) The influence of deep brain stimulation on pain perception in Parkinson’s disease. Mov Disord 26:1367–1368. author reply 1368–1369

    Article  PubMed  Google Scholar 

  125. Ciampi De Andrade DLJ, Galhardoni R et al (2012) Subthalamic deep brain stimulation modulates small fiber-dependent sensory thresholds in Parkinson’s disease. Pain 153:1107–1113

    Article  PubMed  Google Scholar 

  126. Oshima H, Katayama Y, Morishita T et al (2012) Subthalamic nucleus stimulation for attenuation of pain related to Parkinson disease. J Neurosurg 116:99–106

    Article  PubMed  Google Scholar 

  127. Kim HJ, Jeon BS, Lee JY et al (2012) The benefit of subthalamic deep brain stimulation for pain in Parkinson disease: a 2-year follow-up study. Neurosurgery 70:18–23. discussion 14–23

    Article  PubMed  Google Scholar 

  128. Wolz M, Hauschild J, Koy J et al (2012) Immediate effects of deep brain stimulation of the subthalamic nucleus on nonmotor symptoms in Parkinson’s disease. Parkinsonism Relat Disord 18:994–997

    Article  PubMed  Google Scholar 

  129. Surucu O, Baumann-Vogel H, Uhl M et al (2013) Subthalamic deep brain stimulation versus best medical therapy for L-dopa responsive pain in Parkinson’s disease. Pain 154:1477–1479

    Article  PubMed  Google Scholar 

  130. Dellapina E, Ory-Magne F, Regragui W et al (2012) Effect of subthalamic deep brain stimulation on pain in Parkinson’s disease. Pain 153:2267–2273

    Article  PubMed  Google Scholar 

  131. Marques A, Chassin O, Morand D et al (2013) Central pain modulation after subthalamic nucleus stimulation: a crossover randomized trial. Neurology 81:633–640

    Article  PubMed  Google Scholar 

  132. Pellaprat J, Ory-Magne F, Canivet C et al (2014) Deep brain stimulation of the subthalamic nucleus improves pain in Parkinson’s disease. Parkinsonism Relat Disord 20:662–664

    Article  PubMed  Google Scholar 

  133. Cury RG, Galhardoni R, Fonoff ET et al (2014) Effects of deep brain stimulation on pain and other nonmotor symptoms in Parkinson disease. Neurology 83:1403–1409

    Article  PubMed  Google Scholar 

  134. Jung YJ, Kim HJ, Jeon BS et al (2015) An 8-year follow-up on the effect of subthalamic nucleus deep brain stimulation on pain in Parkinson disease. JAMA Neurol 72:504–510

    Article  PubMed  Google Scholar 

  135. Honey CR, Stoessl AJ, Tsui JK et al (1999) Unilateral pallidotomy for reduction of parkinsonian pain. J Neurosurg 91:198–201

    Article  CAS  PubMed  Google Scholar 

  136. Laitinen LV, Bergenheim AT, Hariz MI (1992) Leksell’s posteroventral pallidotomy in the treatment of Parkinson’s disease. J Neurosurg 76:53–61

    Article  CAS  PubMed  Google Scholar 

  137. Rodrigues De Paula F, Teixeira-Salmela LF, Coelho De Morais Faria CD et al (2006) Impact of an exercise program on physical, emotional, and social aspects of quality of life of individuals with Parkinson’s disease. Mov Disord 21:1073–1077

    Article  PubMed  Google Scholar 

  138. Reuter IMS, Leone P, Kaps M, Oechsner M, Engelhardt M (2011) Effects of a flexibility and relaxation programme, walking, and nordic walking on Parkinson’s disease. J Aging Res 2011:Article ID 232473

    Article  Google Scholar 

  139. Donoyama N, Ohkoshi N (2012) Effects of traditional Japanese massage therapy on various symptoms in patients with Parkinson’s disease: a case-series study. J Alternat Complement Med 18:294–299

    Article  Google Scholar 

  140. Shulman LM, Wen X, Weiner WJ et al (2002) Acupuncture therapy for the symptoms of Parkinson’s disease. Mov Disord 17:799–802

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Maurice Wohl Clinical Neuroscience Institute and NIHR Biomedical Research Centre, Institute of Psychiatry, Psychology and Neuroscience, King’s College Hospital, King’s College, London, UK

    Azman Aris, Raquel Taddei, Alexandra Rizos, Anna Sauerbier & K. Ray Chaudhuri

  2. Maurice Wohl Clinical Neuroscience Institute and NIHR Biomedical Research Centre, Institute of Psychiatry, Psychology and Neuroscience, King’s College, London, UK

    Katarina Rukavina

  3. National Parkinson Foundation, Centre of Excellence, King’s College Hospital, London, UK

    Katarina Rukavina

  4. Parkinson Foundation Centre of Excellence, King’s College Hospital, London, UK

    K. Ray Chaudhuri

Authors
  1. Azman Aris
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Katarina Rukavina
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Raquel Taddei
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alexandra Rizos
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Anna Sauerbier
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. K. Ray Chaudhuri
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. National Research Council (CAECHIS-UAI), Buenos Aires, Argentina

    Santiago Perez-Lloret

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Aris, A., Rukavina, K., Taddei, R., Rizos, A., Sauerbier, A., Chaudhuri, K.R. (2021). Clinical Trials on Management of Pain in Parkinson’s Disease. In: Perez-Lloret, S. (eds) Clinical Trials In Parkinson's Disease. Neuromethods, vol 160. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0912-5_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-0716-0912-5_12

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-0716-0911-8

  • Online ISBN: 978-1-0716-0912-5

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation